Tectonic Therapeutic, Inc.
TECX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001681087
In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 115 institutions reported holding it in 13F filings for Q3 2026, worth $332.8M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $419.7M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $13.9K in total
- 2
- 13F holdersQ3 2026, −6 vs. previous quarter
- 115
- 13F valueReported value at the end of Q3 2026
- $332.8M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$74.2M
- No comparable prior period
- Free cash flow, FY2025
- -$60.3M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.38M
- Shares sold short
- Change
- +151.0K
- +6.8% vs. previous
- Days to cover
- 13.66
- At average daily volume
Superinvestors holding TECX, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding TECX at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Tectonic Therapeutic, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 (view filing)5:00 PM ET | Sep 30 | 2 days | McNamara PeterChief Scientific Officer | SSale | −536 | $23.04 | −$12.3K | −1.0%54.3K after | 10b5-1 |
| Aug 26, 2026 (view filing)4:30 PM ET | Aug 25 | 1 day | McNamara PeterChief Scientific Officer | SSale | −43 | $36.52 | −$1.57K | −0.1%55.3K after | 10b5-1 |
| Aug 14, 2026 (view filing)7:25 PM ET | Aug 12 | 2 days | McNamara PeterChief Scientific Officer | SSale | −43 | $35.00 | −$1.50K | −0.1%55.3K after | 10b5-1 |
| Jul 1, 2026 (view filing)5:19 PM ET | Jun 30 | 1 day | McNamara PeterChief Scientific Officer | SSale | −172 | $35.00 | −$6.02K | −0.3%55.3K after | 10b5-1 |
| May 6, 2026 (view filing) | May 4 | 2 days | Ruddy Marcella K.Chief Medical Officer | SSale | −1.06K | $30.00 | −$31.9K | −1.5%67.7K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Ruddy Marcella K.Chief Medical Officer | SSale | −1.00K | $31.05 | −$31.1K | −1.4%68.7K after | 10b5-1 |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | Ruddy Marcella K.Chief Medical Officer | SSale | −10.0K | $30.00 | −$300.0K | −12.5%69.7K after | 10b5-1 |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | McNamara PeterChief Scientific Officer | SSale | −6.26K | $30.17 | −$188.9K | −10.2%55.3K after | 2 lots10b5-1 |
| Mar 5, 2026 (view filing) | Mar 3-4 | 2 days | McNamara PeterChief Scientific Officer | SSale | −3.30K | $23.53 | −$77.6K | −5.3%58.8K after | 2 lots10b5-1 |
| Mar 5, 2026 (view filing) | Feb 11 | 22 days | Reicin AliseChief Executive Officer | PPurchase | +2.50K | $21.10 | +$52.8K | +2.0%127.0K after | Amended |
Top 10 13F holders, Q3 2026
See all 115 holdersThe largest institutional positions in Tectonic Therapeutic, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,932,368 | $68.3M | 0.00% | +101,990+3.6% | Added |
| TCG Crossover Management, LLC | 1,204,891 | $28.1M | 0.79% | 00.0% | Unchanged |
| BlackRock, Inc. | 860,736 | $20.0M | 0.00% | −1,856−0.2% | Reduced |
| Baker Bros. Advisors LP | 607,788 | $14.2M | 0.07% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 606,660 | $14.1M | 4.76% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 512,412 | $11.9M | 0.00% | +23,607+4.8% | Added |
| First Light Asset Management, LLC | 495,950 | $11.6M | 0.68% | −304,776−38.1% | Reduced |
| Standard Life Aberdeen plc | 484,887 | $11.3M | 0.02% | −656,937−57.5% | Reduced |
| Marshall Wace, LLP | 446,511 | $10.4M | 0.01% | +274,410+159.4% | Added |
| Braidwell LP | 371,102 | $8.64M | 0.36% | −225,798−37.8% | Reduced |
Holders of 5% or more of TECX
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Tectonic Therapeutic, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Springer Timothy A | 13D/A | 31.50%4.31M shares | +2.30 ppfrom 29.20% | Jun 26, 20245 filings | Apr 7, 2025 | SEC |
| FMR LLC | 13G/A | 15.00%2.80M shares | +4.70 ppfrom 10.30% | Jul 10, 20244 filings | May 12, 2025 | SEC |
| ADAR1 Partners, LP | 13G | 7.40%3.28M shares | New | Feb 23, 20241 filing | Feb 23, 2024 | SEC |
| McGuire Terrance | 13D/A | 6.30%658.0K shares | 0.00 ppfrom 6.30% | Jun 25, 20243 filings | Apr 7, 2025 | SEC |
| TCG Crossover GP II, LLC | 13G | 6.20%1.17M shares | New | Feb 27, 20261 filing | Feb 27, 2026 | SEC |